| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b92222ce30fec744a456af9b94e32938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6127220ddb418e185da0520a179e09d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d8893a5151d0f07285d24a1bcd214dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca59ab3ad0af474150b9ca746c046a9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd8f384ce8f3589a675e5560e508d86d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
| filingDate |
2006-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ecb0e8c76440b436d390670441cb8c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09eca92ad4921e5b105de5ca666baf57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67a916bd63f390541286ea49d37db647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f646416ac15d979a0a8ea2575c3807e2 |
| publicationDate |
2006-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006089066-A1 |
| titleOfInvention |
Combinations therapy for treatment of demyelinating conditions |
| abstract |
The present invention provides novel methods and compositions for the treatment and prevention of demyelinating conditions. One demyelinating condition treated by the methods and compositions of the invention is multiple sclerosis. Also treated are symptoms associated with multiple sclerosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011157449-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013528632-A |
| priorityDate |
2005-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |